Reaching consensus on drug resistance conferring mutations (Part 1)

by Daniela M Cirillo, Paolo Miotto, Elisa Tagliani
Published 2016-01-01

Cis-acting pathways selectively enforce the non-immunogenicity of shed placental antigen for maternal CD8 T cells.

by Chin-Siean Tay, Elisa Tagliani, Mary K Collins, Adrian Erlebacher
Published 2013-01-01

Applying a Standardized Approach to Strengthen Performances of GeneXpert Networks programme: lessons learned from Burkina Faso, 2019

by Riccardo Alagna, T. Léon Sawadogo, Elisa Tagliani, Adjima Combary, Daniela Maria Cirillo
Published 2020-11-01

Evaluation of Mycobacterium tuberculosis viability in OMNIgene-SPUTUM reagent upon multi-day transport at ambient temperature

by Elisa Tagliani, Riccardo Alagna, Silva Tafaj, Hasan Hafizi, Daniela Maria Cirillo
Published 2017-10-01

Is deployement of diagnostic test alone enough? Comprehensive package of interventions to strengthen TB laboratory network: three years of experience in Burkina Faso

by Riccardo Alagna, Adjima Combary, Elisa Tagliani, Léon Tinnoga Sawadogo, Tandaogo Saouadogo, Souba Diandé, Francis Ouedraogo, Daniela Maria Cirillo
Published 2021-04-01

Mycobacterium sherrisii Pulmonary Disease, Burkina Faso

by Emanuele Borroni, Gisèle Badoum, Daniela Cirillo, Alberto Matteelli, Isidore Moyenga, Martial Ouedraogo, Alberto Roggi, Nuccia Saleri, Elisa Tagliani, Enrico Tortoli
Published 2015-11-01

Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries

by Valérie Schwœbel, Arnaud Trébucq, Zacharie Kashongwe, Alimata S. Bakayoko, Christopher Kuaban, Juergen Noeske, Souleymane H. Harouna, Mahamadou B. Souleymane, Alberto Piubello, François Ciza, Valentin Fikouma, Michel Gasana, Martial Ouedraogo, Martin Gninafon, Armand Van Deun, Elisa Tagliani, Daniela M. Cirillo, Kobto G. Koura, Hans L. Rieder
Published 2020-03-01

Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.

by Jean Claude Semuto Ngabonziza, Awa Ba Diallo, Elisa Tagliani, Bassirou Diarra, Abalo Essosimna Kadanga, Antieme Combo George Togo, Aliou Thiam, Willem Bram de Rijk, Riccardo Alagna, Sabine Houeto, Fatoumata Ba, Anoumou Yaotsè Dagnra, Emil Ivan, Dissou Affolabi, Valérie Schwoebel, Arnaud Trebucq, Bouke Catherine de Jong, Leen Rigouts, Géraldine Daneau, “Union short MDR-TB regimen study group”
Published 2017-01-01

The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing

by Soumitesh Chakravorty, Ann Marie Simmons, Mazhgan Rowneki, Heta Parmar, Yuan Cao, Jamie Ryan, Padmapriya P. Banada, Srinidhi Deshpande, Shubhada Shenai, Alexander Gall, Jennifer Glass, Barry Krieswirth, Samuel G. Schumacher, Pamela Nabeta, Nestani Tukvadze, Camilla Rodrigues, Alena Skrahina, Elisa Tagliani, Daniela M. Cirillo, Amy Davidow, Claudia M. Denkinger, David Persing, Robert Kwiatkowski, Martin Jones, David Alland, Carol A. Nacy
Published 2017-08-01